Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Hiroshi Ito

75 indexed publications match this author name.

ORCID: 0000-0002-9857-8614
OpenAlex: https://openalex.org/A5044544721

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 21 Receptor Pharmacology 19 Pharmacology 17 Mechanism of Action 16 General 15 Animal Study 13 Safety 13 Anxiety 11 Review Article 11 Clinical Trial 9 Neuroplasticity 8 Toxicity 8

Journals

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 7 The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) 4 PsyArXiv 3 British journal of pharmacology 2 Science Letters 2 bioRxiv 2 Toxicology Letters 2 Therapeutic Drug Monitoring 2

Publication history

Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress.Neuropsychopharmacology reports · 2026-09-01 Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.ACS chemical neuroscience · 2026-08-05 Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled TrialClinicalTrials.gov · 2026-07-14 Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open MIND · 2026-07-09 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-03 Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.British journal of pharmacology · 2026-07-01 Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.British journal of pharmacology · 2026-07-01 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-29 Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortexJournal of Psychopharmacology · 2026-06-28 Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative ReviewJournal of Education, Health and Sport · 2026-05-07 Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in ratsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01 Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoformsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01 Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01 Serotonergic Polypharmacology of 2-Halogenated Tryptamines.bioRxiv: the preprint server for biology · 2026-04-21 Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-17 Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-17 Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.Biotechnology and bioengineering · 2026-04-01 Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-25 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01 Retraction: Acute psilocybin increased cortical activities in rats.Frontiers in neuroscience · 2026-01-01 Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval NearseYLS (Yale Law School) · 2025-12-02 Salience, sensemaking, and setting in psilocybin microdosingRepository of the University of Ljubljana (University of Ljubljana) · 2025-11-18 Psilocybin: Systematic review of its use in the treatment of depressionEuropean psychiatry: the journal of the Association of European Psychiatrists · 2025-08-26 Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.Medical science monitor: international medical journal of experimental and clinical research · 2025-08-09 Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.Expert opinion on drug discovery · 2025-02-03 PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)The international journal of neuropsychopharmacology · 2025-02-01 Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10 Alternative therapy for neurological and psychiatric disorders using psilocybinSão Paulo Medical Journal · 2025-01-01 Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2025-01-01 Optimized psilocybin production in tryptophan catabolism-repressed fungi.Microbial biotechnology · 2024-11-01 Distinct classes of antidepressants commonly act to shape pallidal structure and function in micebioRxiv · 2024-09-24 Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.Journal of psychopharmacology (Oxford, England) · 2024-08-01 Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelicsbioRxiv · 2024-06-16 Psilocybin poisoning from Psilocybe argentipes ingestionVisual Journal of Emergency Medicine · 2024-03-11 A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.Biology · 2023-10-28 Is Microdosing a Placebo?PsyArXiv · 2023-06-04 Is Microdosing a Placebo?PsyArXiv · 2023-06-04 Is Microdosing a Placebo?PsyArXiv · 2023-06-04 P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applicationsToxicology Letters · 2022-09-01 P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)Toxicology Letters · 2022-09-01 The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.Neuroscience and biobehavioral reviews · 2022-08-01 Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.Frontiers in epidemiology · 2022-01-01 P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-12-01 Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.Scientific reports · 2021-11-18 Non-Traditional Psychotherapy Techniques: An Assessment of the Value of MDMA, Psilocybin and LSD.Arizona State University Repository · 2021-05-01 Addressing the Implicit Impacts of Sexual Trauma: An Exploration of Somatic Experiencing as an Adjunct to Psilocybin-Assisted TherapyNational University System Repository (National University System) · 2021-04-30 O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depressionBrazilian Journal of Health Review · 2021-04-19 Complete mitochondrial genome sequence of.Mitochondrial DNA. Part B, Resources · 2021-03-18 People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.Drugs (Abingdon, England) · 2021-01-01 The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.Open Repository and Bibliography (University of Liège) · 2020-10-12 The Varieties of Psychedelic EpistemologyUWA Profiles and Research Repository (University of Western Australia) · 2019-10-31 Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.Metabolic engineering · 2018-07-01 Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake RatsBiological ^|^ Pharmaceutical Bulletin · 2015-01-01 Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are OverratedTherapeutic Drug Monitoring · 2014-02-01 Fungal Hallucinogens Psilocin, Ibotenic Acid, and MuscimolTherapeutic Drug Monitoring · 2013-08-01 GAMBARAN KARAKTERISTIK SOSIODEMOGRAFIK, TINGKAT PENGETAHUAN DAN POLA PENGGUNAAN JAMUR Psilocybin PADA MAHASISWA S1 UNIVERSITAS PADJAJARAN PERIODE AJAR2010-2011Universitas Padjadjaran Repository · 2012-01-01 Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in JapanForensic Toxicology · 2009-12-31 Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” userForensic Toxicology · 2006-07-01 Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection.Talanta · 2005-04-30 Liquid Chromatography-Mass Spectrometric and Liquid Chromatography-Tandem Mass Spectrometric Determination of Hallucinogenic Indoles Psilocin and Psilocybin in “Magic Mushroom” SamplesJournal of Forensic and Sciences · 2005-03-01 Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometryAnalytica Chimica Acta · 2004-12-01 Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, PsilocinJournal of Health Science · 2004-01-01 The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31 Morphological and chemical analysis of magic mushrooms in Japan.Forensic science international · 2003-12-17 Optimized glucuronide hydrolysis for the detection of psilocin in human urine samplesJournal of Chromatography B · 2003-11-01 Drugs of abuse monitoring in blood for control of driving under the influence of drugs.Therapeutic drug monitoring · 2002-04-01 Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various originThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1991-12-31 Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratusThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1988-12-31 Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivativesThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1987-12-31 Occurrence of Psilocybin and Baeocystin in the genus Inocybe (Fr.) FrThe Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center) · 1984-12-31 Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbitUA Campus Repository (The University of Arizona) · 1976-12-31

Author directory